Galmed Pharmaceuticals (GLMD) Interest & Investment Income (2018 - 2020)

Galmed Pharmaceuticals' Interest & Investment Income history runs 3 years deep, the most recent figure standing at $725000.0 for Q2 2020.

• In Q2 2020, Interest & Investment Income rose 4431.25% year-over-year to $725000.0; the TTM figure through Jun 2020 stood at $515000.0 (changed N/A YoY), while the FY2020 annual figure was $1.2 million, down 38.97% from the prior year.
• Interest & Investment Income for Q2 2020 stood at $725000.0, up from -$262000.0 in the prior quarter.
• The five-year high for Interest & Investment Income was $725000.0 in Q2 2020, with the low at -$262000.0 in Q1 2020.
• The 3-year median for Interest & Investment Income is $16000.0 (2019), against an average of $97200.0.
• Peak annual rise in Interest & Investment Income reached 4431.25% in 2020, while the deepest fall reached 827.78% in 2020.
• Galmed Pharmaceuticals' Interest & Investment Income stood at -$29000.0 in 2018, then surged by 155.17% to $16000.0 in 2019, then soared by 4431.25% to $725000.0 in 2020.
• Business Quant data shows GLMD's Interest & Investment Income at $725000.0 in Q2 2020, -$262000.0 in Q1 2020, and $16000.0 in Q2 2019.